Reliance Chemotex Industries Ltd AI Stock Analysis
Want to see IN:RELCHEMQ full AI Analyst Report?
Reliance Chemotex Industries Ltd (RELCHEMQ) AI Stock Analysis
Reliance Chemotex Industries Ltd
(NSE:RELCHEMQ)
Weak financial performance from declining earnings, rising leverage, and negative cash flows is the dominant factor weighing on the score, partially offset by moderate technical momentum above key moving averages and reasonable valuation.
Reliance Chemotex Industries Ltd (RELCHEMQ) vs. iShares MSCI India ETF (INDA)
- Market Cap
- INR 911.87M
- Dividend Yield
- 0.41%
- Average Volume (3M)
- 1,175
- Price to Earnings (P/E)
- 10.7
- Beta (1Y)
- 1.26
- Revenue Growth
- 5.85%
- EPS Growth
- 78.72%
- Country
- India
- Employees
- 2,136
- Sector
- General
- Sector Strength
- 55
- Industry
- Manufacturing - Textiles
Reliance Chemotex Industries Ltd Business Overview & Revenue Model
Company Description
Established in 1977, Reliance Chemotex Industries Limited operates from its headquarters in Kolkata, India. The company specializes in the production and global distribution of synthetic and blended yarns, catering to various sectors including home f...
Reliance Chemotex Industries Ltd Financial Statement Overview
Summary
Revenue growth slowed from 38.4% in 2022 to negative in 2025, net income declined sharply with narrowing margins, debt-to-equity rose to 1.9 increasing leverage risk, and operating cash flow turned negative in multiple recent years.
Income Statement
45NeutralBalance Sheet
40NegativeCash Flow
35Negative| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.88B | 3.62B | 3.59B | 3.67B | 3.58B | 3.47B |
| Gross Profit | 1.01B | 714.76M | 1.03B | 507.60M | 570.36M | 1.60B |
| EBITDA | 473.82M | 445.38M | 424.35M | 275.83M | 403.96M | 480.30M |
| Net Income | 84.88M | 52.62M | 40.45M | 32.10M | 124.19M | 181.32M |
Balance Sheet | ||||||
| Total Assets | 5.15B | 5.12B | 4.74B | 4.81B | 3.97B | 3.33B |
| Cash, Cash Equivalents and Short-Term Investments | 132.82M | 128.45M | 112.27M | 503.78M | 613.15M | 576.12M |
| Total Debt | 2.67B | 2.68B | 2.63B | 2.81B | 1.99B | 1.28B |
| Total Liabilities | 3.67B | 3.69B | 3.37B | 3.47B | 2.65B | 2.12B |
| Stockholders Equity | 1.49B | 1.43B | 1.37B | 1.34B | 1.32B | 1.21B |
Cash Flow | ||||||
| Free Cash Flow | 0 | -27.95M | -198.52M | -746.49M | -546.12M | 73.29M |
| Operating Cash Flow | 0 | -20.17M | -108.42M | 179.50M | -386.00K | 593.69M |
| Investing Cash Flow | 0 | -23.96M | 305.42M | -815.32M | -506.77M | -735.50M |
| Financing Cash Flow | 0 | 42.39M | -193.92M | 598.10M | 546.91M | 139.31M |
Reliance Chemotex Industries Ltd Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:RELCHEMQ, the sentiment is Positive. The current price of 121.00 is above the 20-day moving average (MA) of 116.67, above the 50-day MA of 115.34, and above the 200-day MA of 120.48, indicating a bullish trend. The MACD of 2.33 indicates Negative momentum. The RSI at 54.54 is Neutral, neither overbought nor oversold. The STOCH value of 17.57 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:RELCHEMQ.
Reliance Chemotex Industries Ltd Peers Comparison
Overall Rating
IN:ZENITHEXPO54Neutral
IN:NAGREEKEXP51Neutral
IN:RELCHEMQ47Neutral
IN:LOYALTEX47Neutral
IN:SURYALAXMI44Neutral
IN:LOVABLE39Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| 54Neutral | INR 965.93M | 342.31 | ― | ― | -29.69% | -101.02% | |
| 51Neutral | INR 659.05M | 19.14 | ― | ― | 44.36% | 28.93% | |
| 47Neutral | INR 899.57M | 10.74 | ― | 0.41% | 5.85% | 78.72% | |
| 47Neutral | INR 1.08B | -2.40 | ― | ― | -32.94% | -200.37% | |
| 44Neutral | INR 1.07B | 16.42 | ― | ― | 4.18% | 13.51% | |
| 39Underperform | INR 991.90M | 11.60 | ― | ― | 50.00% | 2870.24% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| IN:RELCHEMQ | Reliance Chemotex Industries Ltd | 121.00 | -21.01 | -14.79% | |
| IN:LOVABLE | Lovable Lingerie Limited | 66.91 | -16.26 | -19.55% | |
| IN:LOYALTEX | Loyal Textile Mills Limited | 225.00 | -3.95 | -1.73% | |
| IN:NAGREEKEXP | Nagreeka Exports Ltd | 21.20 | -6.26 | -22.80% | |
| IN:SURYALAXMI | Suryalakshmi Cotton Mills Ltd. | 54.41 | -5.22 | -8.75% | |
| IN:ZENITHEXPO | Zenith Exports Limited | 179.00 | -51.05 | -22.19% |
Reliance Chemotex Industries Ltd Corporate Events
Reliance Chemotex Files SEBI Dematerialization Compliance Certificate for Q2 FY27
Reliance Chemotex Industries Ltd has submitted to BSE and NSE a quarterly confirmation certificate under Regulation 74(5) of SEBI’s Depositories and Participants Regulations, 2018 for the period ended 30 September 2026. The filing affirms that the co...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 06, 2026
